Pulse.

a daily field guide to health research that matters

◆ Console

‹ Thu · 29 Oct 2026
Standard addition

Risk stratification by circulating tumor DNA-based pretreatment genomic profile and post-operative molecular residual disease detection in resectable colorectal oligometastases: PRECISION, a prospective multicenter study

Blood-based tumor markers before surgery and afterward independently predicted recurrence risk in colorectal cancer patients, helping guide follow-up decisions.

This prospective multicenter biomarker cohort study examined Risk stratification by circulating tumor DNA-based pretreatment genomic profile and post-operative molecular residual disease detection in resectable colorectal oligometastases: PRECISION, a prospective multicenter study. Poor pretreatment genomic profiles and postoperative molecular residual disease independently predicted shorter recurrence-free survival and time to surgical failure.

What the study was

Study design
Prospective multicenter biomarker cohort study
Population
Patients with previously untreated resectable colorectal oligometastases
Sample size
118 eligible patients
Category
Genomics/Precision Medicine
Maturity
Exploratory
Journal
ESMO open

Why it surfaced

Prospective multicenter biomarker cohort study; Poor pretreatment genomic profiles and postoperative molecular residual disease independently predicted shorter recurrence-free survival and time to surgical failure. Score kept conservative because only the PubMed abstract and metadata were reviewed.

A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.